High impact
Age-Related Macular Degeneration (CPB 0765, reviewed 2026-01-14)
Aetna·Effective Jan 14, 2026
CPT 67221, in plain terms, covers Using a special light treatment to destroy abnormal blood vessels or tumors in the eye. CPT 67221 is referenced in 1 tracked payer policy change from Aetna. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 67221 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Official descriptor: CPT 67221 on AAPC
Related
Get alerts for changes like this
Save a search and receive a daily digest whenever a new policy change matches your filters.